The following summarizes the depreciation, amortization, personnel costs, and impairment recognized in operating expenses during the three and nine months ended June 30, 2025 and 2024:


	Three months ended June 30,		Nine months ended June 30,
	2025	2024*	2025	2024*
Cost of sales	(7,427)	(6,375)	(20,861)	(16,342)
Selling and distribution expenses	(11,098)	(8,848)	(31,881)	(25,334)
General and administrative expenses	(2,460)	(2,504)	(7,464)	(9,307)
Total depreciation	(20,985)	(17,727)	(60,206)	(50,983)

Cost of sales	(86)	(158)	(194)	(481)
Selling and distribution expenses	(6,440)	(6,708)	(20,018)	(20,114)
General and administrative expenses	(685)	(216)	(1,183)	(615)
Total amortization	(7,211)	(7,082)	(21,395)	(21,210)

Cost of sales	(54,250)	(49,290)	(163,515)	(144,517)
Selling and distribution expenses	(29,464)	(24,982)	(85,457)	(71,528)
General and administrative expenses	(13,941)	(14,744)	(41,465)	(40,847)
Total personnel costs	(97,655)	(89,016)	(290,437)	(256,892)

Cost of sales	(54)	—	(54)	—
Selling and distribution expenses	—	—	(99)	—
Total impairment	(54)	—	(153)	—

*Figures for the three and nine months ended June 30, 2024 have been conformed to the current period presentation.

Additionally, Selling and distribution expenses predominantly consists of selling and marketing expenses as well as logistics expenses. Selling and marketing expenses amounted to €58.9 million and €131.2 million during the three and nine months ended June 30, 2025, respectively. Selling and marketing expenses were €50.3 million and €110.6 million during the three and nine months ended June 30, 2024, respectively. Logistics expenses amounted to €44.1 million and €110.2 million during the three and nine months ended June 30, 2025, respectively. Logistics expenses were €48.7 million and €114.0 million during the three and nine months ended June 30, 2024.